A clinical trial to look at how safe, and how well mosunetuzumab alone or in combination with polatuzumab vedotin works in people with diffuse large B-cell lymphoma
-
Cancer -
Non Hodgkin Lymphoma (NHL) -
Diffuse Large B-Cell Lymphoma (DLBCL)
For the latest version of this information please go to www.forpatients.roche.com